The Current wireless wearable, an upper arm band fitted with a smartphone-sized device, measures patients’ vital signs in real time. Using proprietary artificial intelligence technology, the device can detect warning signs and potential health declines, immediately alerting both the patient and healthcare professional.
According to Current, this is the first end-to-end, real-time-tracking medical wearable and platform to be approved by the FDA. The device aims to decrease hospital readmissions and prevent avoidable disease and death.
The wearable continuously monitors a patient’s respiration rate, oxygen saturation, pulse, temperature and movement, and can connect via Bluetooth with other third-party devices tracking FEV1/FVC ratio, weight, blood pressure, glucose levels and core temperature.
Current users also receive a tablet equipped with a chatbot providing medication reminders, educational information and the ability to communicate with clinicians via video or text.
More articles about AI:
AI startup streamlining electronic medical billing process receives investment from Northwestern Mutual
Member of Google’s disbanded AI ethics team claims she faces retaliation for walkout
Google’s AI-powered healthcare solutions require support from patients, academia, medical community
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.